It is with great sadness that we report the passing of a giant of international rheumatology, Professor Shunle Chen. He was a friend, colleague, collaborator, visionary leader and inspiration to many rheumatologists in China and the world. Moreover, despite his international stature, he was a warm friend and nurturing mentor to all those who had…
Neti Pots, Nurse Ambassadors & American Healthcare
Just YouTube it. As a rheumatologist who sees many patients with granulomatosis with polyangiitis (GPA), I have spent a significant portion of my life talking to people about neti pots. Originally, the neti pot was part of the Ayurvedic tradition. Neti pots were used to flush the sinuses with water, milk and ghee, or to…
Thank You to Our 2020 Authors
The editors of The Rheumatologist would like to thank all of the rheumatologists, rheumatology professionals and professional writers who took the time and effort in an unprecedented pandemic year to ensure we could continue to bring you the important clinical guidelines, case reports, current research, COVID-19 coverage and so much more. This publication would not…
Wisconsin Rheumatology Association Targets Rural Workforce Shortages, Advocacy Needs
Now in its 16th year, the Wisconsin Rheumatology Association engages and supports rheumatology professionals through advocacy sessions, annual meetings and continuing medical education-accredited events.
The ACR Addresses Vaccine Challenges
An ACR COVID-19 Vaccine task force examined vaccine data and literature to evaluate COVID-19 vaccine safety, efficacy and interaction with medications for patients with rheumatic and musculoskeletal diseases, and to craft a living guidance document for members.
Research Coordinators Offer a Lot to Clinical Rheumatology Research Teams
COVID-19 is responsible for many things, including placing public attention on clinical trials and the worldwide race to approve a vaccine. The words rushed to market usually strike fear in the minds and hearts of clinical research coordinators. Many have seen investigational products with aggressive timelines withdrawn mid-study or during late-stage trials. This year, we…
Ethics Forum: Who Did You Vote For? Is a Discussion of Politics in the Medical Office the Taboo It Once Was?
Is it taboo to talk about politics during the office visit? My morning routine may sound familiar to many of you: I wake up and get ready for work. Before I step out of my car, I put on my mask. I go inside the office to greet the staff and to get my temperature…
The Personal Side of COVID-19: A Q&A with Elna Schiopu, MD
Dr. Schiopu has experienced the COVID-19 pandemic response from both clinical and research perspectives. She recently discussed her experiences with The Rheumatologist.
The Glass Ceiling in Academic Rheumatology
Gender plays a role in career advancement among academic rheumatologists in the U.S., according to a new study by Jorge et al.
Medicare’s Most Favored Nation Is My Least Favorite Notion!
In case you missed it, on Nov. 20, the Centers for Medicare & Medicaid Services (CMS), a department within the U.S. Department of Health and Human Services, announced that it will overhaul the payment system for Medicare Part B (i.e., infusion) drugs on Jan. 1, 2021. The plan is called the Most Favored Nation (MFN)…
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 148
- Next Page »